Scholarly Index
Douglas A. Levine
Merck & Co., Inc., Rahway, NJ, USA (United States); 99,858 total citations; 536 total publications; best world rank #21
Merck & Co., Inc., Rahway, NJ, USA (United States)
99,858Total citations
536Total publications
124H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Ovarian cancer diagnosis and treatment | Lifetime | 21 | US 12 | 99.80 |
| Cancer-related molecular mechanisms research | Lifetime | 179 | US 59 | 99.24 |
| Endometrial and Cervical Cancer Treatments | Lifetime | 164 | US 88 | 99.02 |
| BRCA gene mutations in cancer | Lifetime | 144 | US 78 | 98.78 |
| Cancer Genomics and Diagnostics | Lifetime | 690 | US 371 | 98.76 |
| Intraperitoneal and Appendiceal Malignancies | Lifetime | 145 | US 71 | 97.98 |
| PARP inhibition in cancer therapy | Lifetime | 204 | US 104 | 97.22 |
| Cancer Mechanisms and Therapy | Lifetime | 262 | US 123 | 97.31 |
| Chromatin Remodeling and Cancer | Lifetime | 218 | US 113 | 94.49 |